Comparing the current results to its competitors, Guided Therapeutics Inc reported Revenue decrease in the 2 quarter 2026 year on year by 0 %, despite the revenue increase by the most of its competitors of 10.45 %, recorded in the same quarter.
Guided Therapeutics Inc , despite income growth by most of its competitors recorded a net loss, despite income increase by most of its competitors of 27.89 %
Guided Therapeutics Inc 's Comment on Competition and Industry Peers
The company operates in the medical device industry specializing in cervical cancer detection. It competes with providers of cervical cancer detection and prevention products, including screening and diagnostic tests such as the Pap test, HPV test, and colposcopy. Competitors offering new technologies include Hologic with its Thin-Prep system and Qiagen with HPV testing. Spectrascience is developing biophotonic technology products and holds limited FDA approval for a cervical cancer detection device but has not yet entered the market. Additional adjunct devices to colposcopy are being developed by Dysis and Zedco. In April 2014, the FDA approved the Roche cobas HPV test as a primary cervical cancer screening tool, which may compete with the Pap test but has lower specificity.
December 10, 2024
In a significant strategic move, Guided Therapeutics, Inc. the developer of the LuViva Advanced Cervical Scan, has secured a major order from an Indonesian distribution partner, marking a pivotal moment for the company. The order includes four LuViva devices along with 1,200 single-use disposables, which are set to be delivered in the first quarter of 2025. This initial shipment is intended for the government healthcare system in Sulawesi, aimed at improving cervical cancer identification among women a pressing health issue in the region.This venture into Indonesia represents both a marketing win and a crucial expansion for Guided Therapeutics. By introducing its advanced technology to a location with signif...
Escalon Medical Corp is a medical technology company that operates through three segments: ophthalmic diagnostics, ophthalmic surgical and ambulance services. They develop, manufacture and sell a range of medical devices and provide EMS billing services to healthcare providers.
Danaher Corporation operates a diversified business model centered on developing advanced technologies and solutions across multiple sectors, particularly life sciences, diagnostics, dental, and environmental. The company emphasizes continuous innovation and operational excellence, leveraging its proprietary technologies to drive growth and improve efficiency. By strategically acquiring and integrating complementary businesses, Danaher enhances its product offerings while expanding its global market presence.
Boston Scientific Corporations business model centers on creating innovative medical devices for diverse specialties, aimed at addressing unmet medical needs and enhancing patient outcomes. The company sells its products to healthcare professionals and hospitals globally, supported by robust sales and distribution networks. It prioritizes research and development to continually introduce new technologies and solutions.
Becton Dickinson and Company operates a business model focused on developing and providing advanced medical technologies, including a diverse portfolio of medical devices and diagnostic products. Their strategy emphasizes innovation, quality, and strategic partnerships to enhance patient care and streamline healthcare processes across various settings.
Allurion Technologies Inc is a medical device company that specializes in developing non-surgical solutions for weight loss. Their business model is centered around providing a comprehensive weight loss program that combines their innovative medical device, the Elipse Balloon, with personalized coaching and support. They target individuals seeking a non-invasive and convenient approach to achieving their weight loss goals.
Sources:
Guided Therapeutics Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Guided Therapeutics Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
